01 August 2017 |

Innogest invests $3 million in CornerJob

This latest investment follows a $19 million funding announced by the company in May 2017 and takes the total investment in the business to over $57 million, allowing CornerJob to attain a leadership position in digital recruitment in all the countries where it operates (Italy, France, Spain and Mexico)

16 June 2017 |

Bone regeneration, GreenBone raises a €8,4M investment round

GreenBone Ortho, a Faenza (Italy) based company that provides innovative, easy to use bio-inspired solutions designed to help cure severe bone diseases, has raised an investment round led by Helsinn Investment Fund, Invitalia Ventures and Innogest to further develop its revolutionary wood-derived, bone regenerative implant for extensive bone damage

20 March 2017 |

Innogest invests in MedLumics, €34m Series B Round closed

MedLumics, a cardiac device company specializing in optically guided minimally invasive instruments, announced today the largest round in the history of medtech in Spain and one of the largest in Europe this year. Led by Edmond de Rothschild Investment Partners (EdRIP), the Series B round included funding from new investors Seroba Life Sciences, Innogest Capital, as well as from existing investors Ysios Capital Partners and Caixa Capital Risc

20 March 2017 |

Partnership tra ZCube e Innogest per il programma Open Accelerator

Innogest collabora con ZCube, research venture del gruppo farmaceutico Zambon, per la ricerca e lo sviluppo di startup innovative nel campo delle life science, nell'ambito del programma Open Accelerator. Nuova call for ideas in apertura il 3 aprile prossimo

06 March 2017 |

EryDel announces start of ATTEST, Pivotal Phase III Trial in Ataxia Telangiectasia

EryDel SpA, a biopharmaceutical company specialized in the development of drugs and diagnostics delivered through autologous red blood cells, today announced the initiation of the Ataxia Telangiectasia Trial with the EryDex System (ATTEST) study, a pivotal Phase 3 trial to evaluate the efficacy, safety and tolerability of EDS in patients with A-T

11 January 2017 |

Capital increase of over 400.000 euro for Diet to go

Diet to go, an innovative startup that prepares and delivers fresh food based on balanced menus for the purpose of eating healthily and losing weight, closed a capital increase of 430.000 euro subscribed by the Italian venture capital fund Innogest. This operation comes on top of the 40.000 euro, invested by Innogest and Digital Magics, business incubator listed on AIM market of the Italian Stock Exchange, in April 2016

21 December 2016 |

Innogest signed a strategic agreement with Digital Magics

Innogest ha sottoscritto oggi un accordo strategico con Digital Magics, che prevede tra l'altro il conferimento del capitale detenuto da Innogest in Withfounders, società di portafoglio specializzata nell'accelerazione di progetti a livello seed

12 September 2016 |

Launching CV Lab, the first european incubator for cardiovascular projects

Leading entrepreneurs in the cardiovascular sector, together with the most important Italian investors, joined their forces to create an incubator that helps physicians and scientists with innovative projects in the cardiovascular area. CVLab partners with doctors, researcher and technologists to assess their ideas and patents from a business perspective and support the development of the most promising ones toward the market